These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 23579274)
1. BNIP3 acts as transcriptional repressor of death receptor-5 expression and prevents TRAIL-induced cell death in gliomas. Burton TR; Henson ES; Azad MB; Brown M; Eisenstat DD; Gibson SB Cell Death Dis; 2013 Apr; 4(4):e587. PubMed ID: 23579274 [TBL] [Abstract][Full Text] [Related]
2. BNIP3 (Bcl-2 19 kDa interacting protein) acts as transcriptional repressor of apoptosis-inducing factor expression preventing cell death in human malignant gliomas. Burton TR; Eisenstat DD; Gibson SB J Neurosci; 2009 Apr; 29(13):4189-99. PubMed ID: 19339613 [TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319 [TBL] [Abstract][Full Text] [Related]
4. Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway. Cha Z; Cheng J; Xiang H; Qin J; He Y; Peng Z; Jia J; Yu H Cancer Chemother Pharmacol; 2019 Oct; 84(4):719-728. PubMed ID: 31281953 [TBL] [Abstract][Full Text] [Related]
5. Bcl-2 family member Mcl-1 expression is reduced under hypoxia by the E3 ligase FBW7 contributing to BNIP3 induced cell death in glioma cells. Chen Y; Henson ES; Xiao W; Shome E; Azad MB; Burton TR; Queau M; Sathya A; Eisenstat DD; Gibson SB Cancer Biol Ther; 2016 Jun; 17(6):604-13. PubMed ID: 26467103 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of Bcl-2 family members reactivates TRAIL-induced apoptosis in malignant glioma. Hetschko H; Voss V; Horn S; Seifert V; Prehn JH; Kögel D J Neurooncol; 2008 Feb; 86(3):265-72. PubMed ID: 17924059 [TBL] [Abstract][Full Text] [Related]
7. IFN‑β sensitizes TRAIL‑induced apoptosis by upregulation of death receptor 5 in malignant glioma cells. Yoshimura S; Sano E; Hanashima Y; Yamamuro S; Sumi K; Ueda T; Nakayama T; Hara H; Yoshino A; Katayama Y Oncol Rep; 2019 Dec; 42(6):2635-2643. PubMed ID: 31638255 [TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines. Jaganathan J; Petit JH; Lazio BE; Singh SK; Chin LS Neurosurg Focus; 2002 Sep; 13(3):ecp1. PubMed ID: 15844877 [TBL] [Abstract][Full Text] [Related]
9. The Rolipram-Perillyl Alcohol Conjugate (NEO214) Is A Mediator of Cell Death through the Death Receptor Pathway. Cho HY; Thein TZ; Wang W; Swenson SD; Fayngor RA; Ou M; Marín-Ramos NI; Schönthal AH; Hofman FM; Chen TC Mol Cancer Ther; 2019 Mar; 18(3):517-530. PubMed ID: 30647121 [TBL] [Abstract][Full Text] [Related]
10. microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis. Bhere D; Tamura K; Wakimoto H; Choi SH; Purow B; Debatisse J; Shah K Neuro Oncol; 2018 Jan; 20(2):215-224. PubMed ID: 29016934 [TBL] [Abstract][Full Text] [Related]
11. Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5. Chen L; Wolff DW; Xie Y; Lin MF; Tu Y BMC Cancer; 2017 Mar; 17(1):179. PubMed ID: 28270124 [TBL] [Abstract][Full Text] [Related]
12. Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Kim IY; Kang YJ; Yoon MJ; Kim EH; Kim SU; Kwon TK; Kim IA; Choi KS Neuro Oncol; 2011 Mar; 13(3):267-79. PubMed ID: 21292685 [TBL] [Abstract][Full Text] [Related]
13. The pro-cell death Bcl-2 family member, BNIP3, is localized to the nucleus of human glial cells: Implications for glioblastoma multiforme tumor cell survival under hypoxia. Burton TR; Henson ES; Baijal P; Eisenstat DD; Gibson SB Int J Cancer; 2006 Apr; 118(7):1660-9. PubMed ID: 16217754 [TBL] [Abstract][Full Text] [Related]
14. PU.1 supports TRAIL-induced cell death by inhibiting NF-κB-mediated cell survival and inducing DR5 expression. Haimovici A; Humbert M; Federzoni EA; Shan-Krauer D; Brunner T; Frese S; Kaufmann T; Torbett BE; Tschan MP Cell Death Differ; 2017 May; 24(5):866-877. PubMed ID: 28362429 [TBL] [Abstract][Full Text] [Related]
15. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation. Kim JY; Kim EH; Kim SU; Kwon TK; Choi KS Carcinogenesis; 2010 Mar; 31(3):367-75. PubMed ID: 19939880 [TBL] [Abstract][Full Text] [Related]
16. Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization. Cingöz A; Ozyerli-Goknar E; Morova T; Seker-Polat F; Esai Selvan M; Gümüş ZH; Bhere D; Shah K; Solaroglu I; Bagci-Onder T Oncogene; 2021 May; 40(18):3201-3216. PubMed ID: 33767436 [TBL] [Abstract][Full Text] [Related]
17. Importin β1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells. Kojima Y; Nakayama M; Nishina T; Nakano H; Koyanagi M; Takeda K; Okumura K; Yagita H J Biol Chem; 2011 Dec; 286(50):43383-93. PubMed ID: 22020938 [TBL] [Abstract][Full Text] [Related]
18. Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein. Zhitao J; Long L; Jia L; Yunchao B; Anhua W Tumour Biol; 2015 Dec; 36(12):9621-30. PubMed ID: 26142735 [TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of TRAIL and irradiation in elimination of glioblastoma stem-like cells. Liu J; Gao Q; Xie T; Liu Y; Luo L; Xu C; Shen L; Wan F; Lei T; Ye F Clin Exp Med; 2018 Aug; 18(3):399-411. PubMed ID: 29777390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]